text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-2A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

characteristic: host

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-2A MPA01 cells treated with Ciprofloxacin


status: PUBLIC

characteristic: External Id

text: NIEHS Paul Doetsch Group

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Microbe, viral or environmental

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

tag: attribute

text: MPAO1 cells derived from sample P1-2B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

characteristic: description

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

characteristic: organism

characteristic: replicate

text: cell culture

characteristic: strain

text: WGS of Sample P1-2B MPA01 cells treated with Ciprofloxacin

characteristic: title


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-3A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-3A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-3B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-3B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-4A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-4A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-4B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-4B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-5A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-5A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-5B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-5B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-6C were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-6C MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-6D were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-6D MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-7A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-7A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-7B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-7B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-8C were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-8C MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-8D were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-8D MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-9A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-9A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-9B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-9B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C10A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C10A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C1A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C1A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C2A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C2A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C3A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C3A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C4B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C4B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C5A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C5A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C6A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C6A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C7A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C7A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C8A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C8A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P1-C9A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P1-C9A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-10A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-10A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-10B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-10B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-1A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-1A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-1B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-1B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-2A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-2A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-2B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-2B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-3A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-3A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-3B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-3B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-4A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-4A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-4B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-4B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-5A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-5A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-5B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-5B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-6A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-6A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-6B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-6B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-7A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-7A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-7B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-7B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-8A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-8A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-8B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-8B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-9B were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-9B MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-9C were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-9C MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C10A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C10A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C1A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C1A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C2A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C2A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C3A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C3A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C4A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C4A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C5A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C5A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C6A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C6A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C7A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C7A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C8A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C8A MPA01 cells treated with Ciprofloxacin


text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample P2-C9A were seeded from a frozen stock in 5 ml of LB media containing 2 ug/ml ciprofloxacion and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Sample P2-C9A MPA01 cells treated with Ciprofloxacin


WT

text: NIEHS Paul Doetsch Group

text: live

text: Microbe, viral or environmental

text: MPAO1 cells derived from sample WT were seeded from a frozen stock in 5 ml of LB media and grown at 37C until saturation. Cells were collected and DNA was extracted using a Maxwell® RSC Cultured Cells DNA Kit (Promega) and its quality determined in an Agilent 5200 Fragment Analyzer System using a Genomic DNA 50kb Kit (Agilent). Indexed pair-end libraries were prepared with TruSeq DNA Library Prep Kit (Illumina Inc, USA) and sequenced on a NextSeq 550 System Mid-Output Flowcell (Illumina Inc, USA) in a NextSeq 500 System Whole-Genome Sequencing Solution (Illumina Inc, USA). The resulting paired-end reads were 150 bp long.

text: USA: Durham, NC

text: not applicable

text: not applicable

text: Pseudomonas aeruginosa

text: cell culture

text: WGS of Wild-type MPA01 cells


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01464/2023

characteristic: isolate

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01465/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01466/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01467/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01468/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01469/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01470/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01471/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01472/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01473/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01474/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01475/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01476/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01477/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01478/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01479/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01480/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01481/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01482/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01483/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01484/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01485/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01486/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01487/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01488/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01489/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01490/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01491/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01492/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01493/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01494/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01495/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01496/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01497/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01498/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01499/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01500/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01501/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01502/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: WestPac Labs

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01503/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: WestPac Labs

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01504/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01505/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01506/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01507/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01508/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01509/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01510/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01511/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01512/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01513/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01514/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01515/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01516/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01517/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01518/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01519/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01520/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01521/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01522/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01523/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: UCLA Health Care Clinical Laboratory - Brentwood

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01524/2023

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01525/2023

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01526/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01527/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01528/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01529/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01530/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01531/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01532/2023

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01533/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: BIOLOGICAL LABORATORY, INC

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01534/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01535/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01536/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01537/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01538/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01539/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01540/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01541/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01542/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Healthy Care Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01543/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01544/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01545/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01546/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01547/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01548/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01549/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01550/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01551/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01552/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01553/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01554/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01555/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01556/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01557/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01558/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01559/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01560/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01561/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01562/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Huntington Memorial Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01563/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01564/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01565/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: PIH Health Whittier Hospital

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01566/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Avellino Labs

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01567/2023

text: clinical

text: Baseline Surveillance


text: CHINA PHARMCUTICAL UNIVERSITY

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

characteristic: tissue

text: CRS skin 3

text: chronic restraint stress

characteristic: treatment


characteristic: External Id

text: CHINA PHARMCUTICAL UNIVERSITY

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

text: CRS skin 2

text: chronic restraint stress


text: CHINA PHARMCUTICAL UNIVERSITY

characteristic: INSDC center name

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

text: CRS skin 1

text: chronic restraint stress


text: CHINA PHARMCUTICAL UNIVERSITY

characteristic: INSDC first public

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

text: CON skin 3

text: control


text: CHINA PHARMCUTICAL UNIVERSITY

characteristic: INSDC last update

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

text: CON skin 2

text: control


text: CHINA PHARMCUTICAL UNIVERSITY

characteristic: INSDC secondary accession

text: live

text: Generic

text: missing

text: missing

text: Mus musculus

text: skin

text: skin

text: CON skin 1

text: control


text: Minnesota Department of Health Infectious Disease Laboratory Submission Group

text: live

characteristic: INSDC status

characteristic: MLST

text: Microbe, viral or environmental

text: USA

text: Homo sapiens

characteristic: host

text: stool

text: Clostridioides difficile

text: Microbe sample from Clostridioides difficile


text: Texas Tech University

text: live

text: Plant

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: Mature

text: USA: Ruidoso, New Mexico

text: Male

text: Salix exigua

text: Leaf

text: Plant sample from Salix exigua


text: Texas Tech University

text: live

text: Plant

text: Mature

text: USA: Ruidoso, New Mexico

text: Female

text: Salix exigua

characteristic: organism

text: Leaf

text: Plant sample from Salix exigua


text: Naresuan University

text: live

text: Metagenome or environmental

text: Thailand:Phitsanulok

text: Columba livia

text: Faecal collected from wild pigeons in Thailand

text: not applicable

text: viral metagenome

text: PLK01 pool

text: Viral metagenome isolated from faecal samples of wild pigeons


text: CDC GCWGS

text: live

text: Pathogen.cl

text: CDC

text: Homo sapiens

text: Gonorrhea

text: male

text: Urethral

text: pathogen.cl

text: missing

text: Neisseria gonorrhoeae

characteristic: strain


text: CDC GCWGS

text: live

text: Pathogen.cl

text: CDC

text: Homo sapiens

text: Gonorrhea

text: male

text: Pharyngeal

text: pathogen.cl

text: missing

text: Neisseria gonorrhoeae

characteristic: title


text: Naresuan University

text: live

text: Metagenome or environmental

text: Thailand:Phitsanulok

text: Columba livia

text: not applicable

text: viral metagenome

text: PLK02 pool


text: PulseNet Next Generation Subtyping Methods Unit

text: live

text: Pathogen.env

text: NM

text: missing

text: USA:NM

characteristic: isolate

text: chicken

text: missing

text: Campylobacter coli

text: Campylobacter coli


text: IN Ximenes microbial pathogen submission group

text: live

text: Pathogen.env

text: Innovation Center Laboratory of Microbiology at Indiana University

text: USA:IN

text: ground turkey

text: 39.66510110 N 86.18265278 W

text: Salmonella enterica

text: Ground Turkey


text: Rossi, School of Biomedical Engineering, University of British Columbia

text: live

text: Generic

text: DPPIV+ FAPs

characteristic: cell type

text: missing

text: Wild-type mice subjected to 3 weeks of CSF1R inhibition followed by 3 days of a regular diet

characteristic: genotype

text: missing

text: Mus musculus

text: Tibialis Anterior

text: CSF1R inh/wd D3


characteristic: External Id

text: live

text: Generic

text: DPPIV- FAPs

text: missing

text: missing

text: Mus musculus

text: Tibialis Anterior

text: CSF1R inh/wd D3

characteristic: treatment


text: Texas Department of State Health Services-ARLN/HAI-Seq submission group

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Microbe, viral or environmental

text: USA

text: Homo sapiens

text: missing

text: Not Provided

text: Staphylococcus aureus

text: whole organism

text: Microbe sample from Staphylococcus aureus


text: Los Angeles County Public Health Lab microbial pathogen submission group

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01587/2023

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

characteristic: INSDC status

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01583/2023

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01584/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

characteristic: NCBI submission model

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01586/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

characteristic: NCBI submission package

text: Primex Clinical Laboratories

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01580/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

characteristic: SRA accession

text: Providence Saint John's Health Center

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01582/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Providence Saint John's Health Center

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01585/2023

text: clinical

characteristic: organism

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Providence Saint John's Health Center

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01575/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Providence Saint John's Health Center

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01576/2023

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01581/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01579/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01588/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01568/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01573/2022

text: clinical

text: Baseline Surveillance


text: Los Angeles County Public Health Lab microbial pathogen submission group

text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01589/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01574/2022

text: clinical

text: Baseline Surveillance

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01570/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01577/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01569/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01578/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: USC Clinical Lab

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01572/2022

text: clinical

text: Baseline Surveillance


text: live

text: SARS-CoV-2: clinical or host-associated

text: Providence Saint John's Health Center

text: USA: California, Los Angeles County

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-LACPHL-AY01571/2023

text: clinical

text: Baseline Surveillance


text: University of Ottawa

text: live

text: MIGS/MIMS/MIMARKS.host-associated

text: MIMARKS.survey

text: Keywords: GSC:MIxS;MIMARKS:6.0

characteristic: description

text: Chicken biome

text: Stool

text: Stool

text: Canada: Ottawa

text: Gallus gallus

text: 45.4215 N 75.6972 W

text: gut metagenome


text: Johns Hopkins University

text: live

text: Pathogen.cl

text: DA

text: USA

text: Homo sapiens

text: Tuberculosis

text: 10 microgram per ml Contezolid

text: in-vitro

text: 39.29585122 N 76.59640960 W

text: Mycobacterium tuberculosis H37Rv

characteristic: strain

text: Pathogen: clinical or host-associated sample from Mycobacterium tuberculosis H37Rv

characteristic: title

text: type strain of Mycobacterium tuberculosis

characteristic: type-material


text: Johns Hopkins University

text: live

text: Pathogen.cl

text: DA

text: USA

text: Homo sapiens

text: Tuberculosis

text: 3 microgram per ml contezolid

characteristic: isolate

text: in-vitro

text: 39.29585122 N 76.59640960 W

text: Mycobacterium tuberculosis H37Rv


characteristic: External Id

text: PulseNet Next Generation Subtyping Methods Unit

text: live

text: Pathogen.cl

text: CDC

text: USA

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: Escherichia coli

characteristic: serovar

text: Escherichia coli


characteristic: ID

text: Virginia Division of Consolidated Laboratory Services Sequencing Submission Group

characteristic: INSDC center name

text: live

text: Pathogen.cl

text: USA

text: Homo sapiens

text: not provided

text: urine

text: not provided

text: Klebsiella pneumoniae

text: Pathogen: clinical or host-associated sample from Klebsiella pneumoniae


characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Pathogen.cl

text: USA

text: Homo sapiens

text: not provided

text: urine

text: not provided

text: Acinetobacter baumannii

text: Pathogen: clinical or host-associated sample from Acinetobacter baumannii


characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Pathogen.cl

text: USA

text: Homo sapiens

text: not provided

text: wound

text: not provided

text: Acinetobacter baumannii


text: live

text: Pathogen.cl

characteristic: NCBI submission model

text: USA

text: Homo sapiens

characteristic: host

text: not provided

text: blood

text: not provided

text: Klebsiella pneumoniae


text: live

text: Pathogen.cl

characteristic: NCBI submission package

characteristic: SRA accession

text: USA

text: Homo sapiens

text: not provided

text: tracheal aspirate

text: not provided

text: Klebsiella pneumoniae


text: live

text: Pathogen.cl

text: USA

text: Homo sapiens

text: not provided

text: bronchial alveolar lavage

text: not provided

text: Citrobacter farmeri

characteristic: organism

text: Pathogen: clinical or host-associated sample from Citrobacter farmeri


text: live

text: Pathogen.cl

text: CDC

text: missing

text: USA

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: Escherichia coli

text: missing

characteristic: strain

text: Escherichia coli


text: live

text: Pathogen.cl

text: CDC

text: missing

text: USA

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: Listeria monocytogenes

text: missing

text: Listeria monocytogenes

characteristic: title


text: live

text: Pathogen.cl

text: CDC

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: Listeria monocytogenes

text: missing

text: Listeria monocytogenes


text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

text: rotten logs

text: Euperipatoides rowelli

text: male

characteristic: sex

text: slime gland reservoir

characteristic: tissue

text: Euperipatoides rowelli: slime gland reservoir, ER_AB1


characteristic: External Id

text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

characteristic: isolate

text: rotten logs

text: Euperipatoides rowelli

text: male

text: slime gland endpieces + last part of duct

text: Euperipatoides rowelli: slime gland endpieces, ER_AB1


text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

text: rotten logs

text: Euperipatoides rowelli

text: male

text: slime gland duct + some of endpieces

text: Euperipatoides rowelli: slime gland duct, ER_AB1


text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

text: rotten logs

text: Euperipatoides rowelli

text: male

text: midgut

text: Euperipatoides rowelli: gut, ER_AB1


text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

text: rotten logs

text: Euperipatoides rowelli

text: male

text: slime gland endpieces + some duct

text: Euperipatoides rowelli: slime gland endpieces, ER_AB2


text: University of Kassel

text: live

text: Invertebrate

text: adult

text: Australia: Tallaganda State Forest, NSW

text: rotten logs

text: Euperipatoides rowelli

text: male

text: slime gland endpieces + some duct

text: Euperipatoides rowelli: slime gland endpieces, ER_AB3


text: live

text: Pathogen.cl

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: missing

text: Escherichia coli

characteristic: serovar

text: Escherichia coli


text: University of Iowa

characteristic: INSDC center name

text: live

text: Pathogen.cl

text: missing

text: USA

text: Homo sapiens

text: missing

text: urine

text: missing

text: Proteus mirabilis

text: Pathogen: clinical or host-associated sample from Proteus mirabilis


text: University of Iowa

characteristic: INSDC first public

text: live

text: Pathogen.cl

text: missing

text: USA

text: Homo sapiens

text: missing

text: urine

text: missing

text: Morganella morganii

text: Pathogen: clinical or host-associated sample from Morganella morganii


text: University of Iowa

characteristic: INSDC last update

text: live

text: Pathogen.cl

text: missing

text: USA

text: Homo sapiens

text: missing

text: missing

text: missing

text: Escherichia coli

text: Pathogen: clinical or host-associated sample from Escherichia coli


text: University of Iowa

characteristic: INSDC secondary accession

text: live

text: Pathogen.cl

text: missing

text: USA

text: Homo sapiens

text: missing

text: Calf

text: missing

text: Providencia stuartii

text: Pathogen: clinical or host-associated sample from Providencia stuartii


text: University of Iowa

text: live

characteristic: INSDC status

text: Pathogen.cl

text: missing

text: USA

text: Homo sapiens

text: missing

text: sputum

text: missing

text: Acinetobacter baumannii